 | • レポートコード：MRC2312MG14373 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の肺動脈弁人工血管市場規模と予測を収録しています。・世界の肺動脈弁人工血管市場：売上、2018年-2023年、2024年-2029年 ・世界の肺動脈弁人工血管市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の肺動脈弁人工血管市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「生体材料」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 肺動脈弁人工血管のグローバル主要企業は、Medtronic、 Xeltis、 Edwards Lifesciences、 Labcor、 Balance Medicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、肺動脈弁人工血管のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の肺動脈弁人工血管市場：タイプ別、2018年-2023年、2024年-2029年 世界の肺動脈弁人工血管市場：タイプ別市場シェア、2022年 ・生体材料、高分子合成材料 世界の肺動脈弁人工血管市場：用途別、2018年-2023年、2024年-2029年 世界の肺動脈弁人工血管市場：用途別市場シェア、2022年 ・病院、診療所 世界の肺動脈弁人工血管市場：地域・国別、2018年-2023年、2024年-2029年 世界の肺動脈弁人工血管市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における肺動脈弁人工血管のグローバル売上、2018年-2023年 ・主要企業における肺動脈弁人工血管のグローバル売上シェア、2022年 ・主要企業における肺動脈弁人工血管のグローバル販売量、2018年-2023年 ・主要企業における肺動脈弁人工血管のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Medtronic、 Xeltis、 Edwards Lifesciences、 Labcor、 Balance Medical ************************************************************* ・調査・分析レポートの概要 肺動脈弁人工血管市場の定義 市場セグメント 世界の肺動脈弁人工血管市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の肺動脈弁人工血管市場規模 世界の肺動脈弁人工血管市場規模：2022年 VS 2029年 世界の肺動脈弁人工血管市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの肺動脈弁人工血管の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の肺動脈弁人工血管製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：生体材料、高分子合成材料 肺動脈弁人工血管のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所 肺動脈弁人工血管の用途別グローバル売上・予測 ・地域別市場分析 地域別肺動脈弁人工血管市場規模 2022年と2029年 地域別肺動脈弁人工血管売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Medtronic、 Xeltis、 Edwards Lifesciences、 Labcor、 Balance Medical ... |
This research report provides a comprehensive analysis of the Pulmonary Valved Conduit market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Pulmonary Valved Conduit market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Pulmonary Valved Conduit, challenges faced by the industry, and potential opportunities for market players.
The global Pulmonary Valved Conduit market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Pulmonary Valved Conduit market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Pulmonary Valved Conduit market. Additionally, the growing consumer demand present avenues for market expansion.
The global Pulmonary Valved Conduit market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Pulmonary Valved Conduit market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Pulmonary Valved Conduit market.
Market Overview: The report provides a comprehensive overview of the Pulmonary Valved Conduit market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Biological Materials, Polymer Synthetic Materials), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Pulmonary Valved Conduit market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Pulmonary Valved Conduit market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Pulmonary Valved Conduit market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Pulmonary Valved Conduit market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Pulmonary Valved Conduit market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Pulmonary Valved Conduit market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Pulmonary Valved Conduit, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Pulmonary Valved Conduit market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Pulmonary Valved Conduit market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Biological Materials
Polymer Synthetic Materials
Market segment by Application
Hospital
Clinic
Global Pulmonary Valved Conduit Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Medtronic
Xeltis
Edwards Lifesciences
Labcor
Balance Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pulmonary Valved Conduit, market overview.
Chapter 2: Global Pulmonary Valved Conduit market size in revenue and volume.
Chapter 3: Detailed analysis of Pulmonary Valved Conduit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pulmonary Valved Conduit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pulmonary Valved Conduit capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Pulmonary Valved Conduit Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Valved Conduit Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Valved Conduit Overall Market Size
2.1 Global Pulmonary Valved Conduit Market Size: 2022 VS 2029
2.2 Global Pulmonary Valved Conduit Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pulmonary Valved Conduit Sales: 2018-2029
3 Company Landscape
3.1 Top Pulmonary Valved Conduit Players in Global Market
3.2 Top Global Pulmonary Valved Conduit Companies Ranked by Revenue
3.3 Global Pulmonary Valved Conduit Revenue by Companies
3.4 Global Pulmonary Valved Conduit Sales by Companies
3.5 Global Pulmonary Valved Conduit Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pulmonary Valved Conduit Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pulmonary Valved Conduit Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Valved Conduit Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Valved Conduit Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Valved Conduit Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pulmonary Valved Conduit Market Size Markets, 2022 & 2029
4.1.2 Biological Materials
4.1.3 Polymer Synthetic Materials
4.2 By Type – Global Pulmonary Valved Conduit Revenue & Forecasts
4.2.1 By Type – Global Pulmonary Valved Conduit Revenue, 2018-2023
4.2.2 By Type – Global Pulmonary Valved Conduit Revenue, 2024-2029
4.2.3 By Type – Global Pulmonary Valved Conduit Revenue Market Share, 2018-2029
4.3 By Type – Global Pulmonary Valved Conduit Sales & Forecasts
4.3.1 By Type – Global Pulmonary Valved Conduit Sales, 2018-2023
4.3.2 By Type – Global Pulmonary Valved Conduit Sales, 2024-2029
4.3.3 By Type – Global Pulmonary Valved Conduit Sales Market Share, 2018-2029
4.4 By Type – Global Pulmonary Valved Conduit Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pulmonary Valved Conduit Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application – Global Pulmonary Valved Conduit Revenue & Forecasts
5.2.1 By Application – Global Pulmonary Valved Conduit Revenue, 2018-2023
5.2.2 By Application – Global Pulmonary Valved Conduit Revenue, 2024-2029
5.2.3 By Application – Global Pulmonary Valved Conduit Revenue Market Share, 2018-2029
5.3 By Application – Global Pulmonary Valved Conduit Sales & Forecasts
5.3.1 By Application – Global Pulmonary Valved Conduit Sales, 2018-2023
5.3.2 By Application – Global Pulmonary Valved Conduit Sales, 2024-2029
5.3.3 By Application – Global Pulmonary Valved Conduit Sales Market Share, 2018-2029
5.4 By Application – Global Pulmonary Valved Conduit Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pulmonary Valved Conduit Market Size, 2022 & 2029
6.2 By Region – Global Pulmonary Valved Conduit Revenue & Forecasts
6.2.1 By Region – Global Pulmonary Valved Conduit Revenue, 2018-2023
6.2.2 By Region – Global Pulmonary Valved Conduit Revenue, 2024-2029
6.2.3 By Region – Global Pulmonary Valved Conduit Revenue Market Share, 2018-2029
6.3 By Region – Global Pulmonary Valved Conduit Sales & Forecasts
6.3.1 By Region – Global Pulmonary Valved Conduit Sales, 2018-2023
6.3.2 By Region – Global Pulmonary Valved Conduit Sales, 2024-2029
6.3.3 By Region – Global Pulmonary Valved Conduit Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pulmonary Valved Conduit Revenue, 2018-2029
6.4.2 By Country – North America Pulmonary Valved Conduit Sales, 2018-2029
6.4.3 US Pulmonary Valved Conduit Market Size, 2018-2029
6.4.4 Canada Pulmonary Valved Conduit Market Size, 2018-2029
6.4.5 Mexico Pulmonary Valved Conduit Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pulmonary Valved Conduit Revenue, 2018-2029
6.5.2 By Country – Europe Pulmonary Valved Conduit Sales, 2018-2029
6.5.3 Germany Pulmonary Valved Conduit Market Size, 2018-2029
6.5.4 France Pulmonary Valved Conduit Market Size, 2018-2029
6.5.5 U.K. Pulmonary Valved Conduit Market Size, 2018-2029
6.5.6 Italy Pulmonary Valved Conduit Market Size, 2018-2029
6.5.7 Russia Pulmonary Valved Conduit Market Size, 2018-2029
6.5.8 Nordic Countries Pulmonary Valved Conduit Market Size, 2018-2029
6.5.9 Benelux Pulmonary Valved Conduit Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pulmonary Valved Conduit Revenue, 2018-2029
6.6.2 By Region – Asia Pulmonary Valved Conduit Sales, 2018-2029
6.6.3 China Pulmonary Valved Conduit Market Size, 2018-2029
6.6.4 Japan Pulmonary Valved Conduit Market Size, 2018-2029
6.6.5 South Korea Pulmonary Valved Conduit Market Size, 2018-2029
6.6.6 Southeast Asia Pulmonary Valved Conduit Market Size, 2018-2029
6.6.7 India Pulmonary Valved Conduit Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pulmonary Valved Conduit Revenue, 2018-2029
6.7.2 By Country – South America Pulmonary Valved Conduit Sales, 2018-2029
6.7.3 Brazil Pulmonary Valved Conduit Market Size, 2018-2029
6.7.4 Argentina Pulmonary Valved Conduit Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pulmonary Valved Conduit Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pulmonary Valved Conduit Sales, 2018-2029
6.8.3 Turkey Pulmonary Valved Conduit Market Size, 2018-2029
6.8.4 Israel Pulmonary Valved Conduit Market Size, 2018-2029
6.8.5 Saudi Arabia Pulmonary Valved Conduit Market Size, 2018-2029
6.8.6 UAE Pulmonary Valved Conduit Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Pulmonary Valved Conduit Major Product Offerings
7.1.4 Medtronic Pulmonary Valved Conduit Sales and Revenue in Global (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Xeltis
7.2.1 Xeltis Company Summary
7.2.2 Xeltis Business Overview
7.2.3 Xeltis Pulmonary Valved Conduit Major Product Offerings
7.2.4 Xeltis Pulmonary Valved Conduit Sales and Revenue in Global (2018-2023)
7.2.5 Xeltis Key News & Latest Developments
7.3 Edwards Lifesciences
7.3.1 Edwards Lifesciences Company Summary
7.3.2 Edwards Lifesciences Business Overview
7.3.3 Edwards Lifesciences Pulmonary Valved Conduit Major Product Offerings
7.3.4 Edwards Lifesciences Pulmonary Valved Conduit Sales and Revenue in Global (2018-2023)
7.3.5 Edwards Lifesciences Key News & Latest Developments
7.4 Labcor
7.4.1 Labcor Company Summary
7.4.2 Labcor Business Overview
7.4.3 Labcor Pulmonary Valved Conduit Major Product Offerings
7.4.4 Labcor Pulmonary Valved Conduit Sales and Revenue in Global (2018-2023)
7.4.5 Labcor Key News & Latest Developments
7.5 Balance Medical
7.5.1 Balance Medical Company Summary
7.5.2 Balance Medical Business Overview
7.5.3 Balance Medical Pulmonary Valved Conduit Major Product Offerings
7.5.4 Balance Medical Pulmonary Valved Conduit Sales and Revenue in Global (2018-2023)
7.5.5 Balance Medical Key News & Latest Developments
8 Global Pulmonary Valved Conduit Production Capacity, Analysis
8.1 Global Pulmonary Valved Conduit Production Capacity, 2018-2029
8.2 Pulmonary Valved Conduit Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Valved Conduit Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Valved Conduit Supply Chain Analysis
10.1 Pulmonary Valved Conduit Industry Value Chain
10.2 Pulmonary Valved Conduit Upstream Market
10.3 Pulmonary Valved Conduit Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Valved Conduit Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
